Healthtech Startups

BrainHi builds AI-powered patient communication and healthcare access solutions for underserved populations, particularly in Puerto Rico and beyond. The platform automates patient interactions and provides continuous availability for calls and messages to close gaps in healthcare access.

3 investors

3 investors

Braveheart develops treatments for hypertrophic cardiomyopathy and related cardiac conditions. The company focuses on improving the standard of care for patients with these disease types.

3 investors

BRCĒ Sports manufactures engineered shoelaces designed for athletic performance, with sport-specific tension and width calibration to improve ankle lockdown and stability during physical activity.

3 investors

Brevy is a free online platform that helps individuals discover and enroll in Medicaid and Medicare benefits tailored to their eligibility. It serves caregivers, seniors, and families seeking benefits including paid caregiver programs, financial assistance, housing support, and medication coverage.

3 investors

Bright Minds Biosciences develops selective serotonin receptor agonists (5-HT2A and 5-HT2C) without 5-HT2B activity, built on a proprietary chemistry platform. The company targets central nervous system and brain disorders through serotonin regulation.

3 investors

Bristle provides digital tools and insights to help people assess and improve their oral health, positioning dental care as a preventive step toward overall wellness.

3 investors

Briya builds a data exchange infrastructure that connects healthcare organizations and life sciences organizations to share high-quality medical and clinical data securely and compliantly. The platform is aimed at researchers and hospitals to speed access to data for medical research and treatment development.

3 investors

Buck Surgical develops surgical technologies aimed at improving outcomes for complex procedures and expanding patient access to reconstructive and limb-preserving treatments. The company focuses on new anastomotic and surgical devices for plastic and reconstructive surgery.

3 investors

Buoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers. It also publishes health content reviewed by clinicians such as doctors, nurses, and therapists.

3 investors

Burst helps consumers get reimbursed for health and wellness purchases through their FSA and HSA accounts by handling claims processing and eligibility verification. The platform connects users' FSA/HSA accounts to determine reimbursement eligibility for a wide range of health products and services.

3 investors

BurstIQ builds LifeGraph, a privacy-first, blockchain-enabled data management platform that connects fragmented data into AI-ready intelligence while maintaining HIPAA, GDPR, and FERPA compliance for regulated industries.

3 investors

Busy makes individually wrapped body, face, and deodorant wipes formulated with skincare ingredients for quick self-care and cleansing. The consumer personal-care products are sold direct to consumers, including via Amazon.

3 investors

Buymed operates a digital pharmaceutical supply chain connecting manufacturers, distributors, hospitals, and pharmacies through B2B ordering and retail pharmacy networks. It serves the pharmaceutical market in Vietnam and Southeast Asia with transparent pricing, product variety, and delivery tracking.

3 investors

ByHeart is an infant formula company that manufactures science-driven baby formula with its own manufacturing process and supply chain. The page addresses a Clostridium botulinum contamination outbreak and outlines new testing protocols and safety controls for its products, sold to families in the US.

3 investors

C8 Health is an AI clinical performance platform that consolidates protocols, checklists, training materials, and schedules into a single source of truth and delivers vetted best practices to clinicians at the point of care. It serves hospitals and healthcare institutions.

3 investors

Caedo Oncology develops therapeutic antibodies for cancer treatment, leveraging deep immunology and antibody engineering expertise.

3 investors

Caldera is a clinical-stage biotechnology company developing CLD-423, a bispecific antibody targeting the IL-23p19 and TL1A pathways for inflammatory bowel disease and other immunologic and inflammatory diseases. Its lead candidate is in a Phase 1 healthy volunteer trial.

3 investors

Calorify measures individual metabolic rates and energy expenditure using doubly labeled water, a scientific method to quantify the calories people burn. The service targets individuals interested in understanding their personal metabolism and optimizing performance.

3 investors

Camstent develops coated medical devices using proprietary bacteriophobic polymer technology to reduce biofilm formation and infection risk on silicon-based medical devices, particularly catheters. The company addresses hospital-acquired infections, which represent a significant burden on healthcare systems and patient outcomes.

3 investors

Canopie provides digital mental health support focused on preventing and addressing maternal perinatal health conditions. The platform serves pregnant people and new mothers through therapeutic content, community classes, and evidence-based interventions designed for underserved and marginalized populations.

3 investors

Canopy operates an Intelligent Care Platform for oncology practices, using data-driven software to support continuous care for cancer patients and caregivers. Its tools help care teams improve patient outcomes and experience throughout the cancer journey.

3 investors

CapExpert is an AI-powered platform for healthcare asset management, letting providers inventory, maintain, source, and redeploy capital medical equipment across its lifecycle. It serves healthcare providers and vendors, positioning itself as an operating system for medical equipment.

3 investors

Capstan Medical develops surgical robotics combined with catheter-based technology and next-generation implants to repair and replace heart valves. Its minimally invasive approach targets structural heart disease, including mitral and tricuspid valve conditions, as an alternative to open heart surgery.

3 investors